| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.18 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |